Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
äŒæ¥ã³ãŒãTNDM
äŒç€ŸåTandem Diabetes Care Inc
äžå Žæ¥Nov 13, 2013
æé«çµå¶è²¬ä»»è
ãCEOãSheridan (John F)
åŸæ¥å¡æ°2650
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Nov 13
æ¬ç€Ÿæåšå°12400 High Bluff Drive
éœåžSAN DIEGO
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·92130
é»è©±çªå·18583666900
ãŠã§ããµã€ãhttps://www.tandemdiabetes.com/
äŒæ¥ã³ãŒãTNDM
äžå Žæ¥Nov 13, 2013
æé«çµå¶è²¬ä»»è
ãCEOãSheridan (John F)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã